{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T20:19:53Z","timestamp":1781900393682,"version":"3.54.5"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T00:00:00Z","timestamp":1712016000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","atherosclerosis-journal.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.atherosclerosis.2024.117488","type":"journal-article","created":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T15:10:12Z","timestamp":1711465812000},"page":"117488","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Ten-year mortality after treating obstructive coronary atherosclerosis with contemporary stents in patients with or without concomitant peripheral arterial disease"],"prefix":"10.1016","volume":"392","author":[{"given":"Tineke H.","family":"Pinxterhuis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eline H.","family":"Ploumen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphne","family":"van Vliet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Gert van Houwelingen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin G.","family":"Stoel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frits HAF.","family":"de Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Zocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard CM.","family":"Linssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"Geelkerken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine JM.","family":"Doggen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5128-2832","authenticated-orcid":false,"given":"Clemens","family":"von Birgelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.atherosclerosis.2024.117488_bib1","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1161\/hc4201.098056","article-title":"Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up","volume":"104","author":"Sousa","year":"2001","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2024.117488_bib2","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1161\/CIRCULATIONAHA.118.038065","article-title":"Ten-year clinical outcomes from a trial of three Limus-eluting stents with different polymer coatings in patients with coronary artery disease","volume":"139","author":"Kufner","year":"2019","journal-title":"Circulation"},{"issue":"69","key":"10.1016\/j.atherosclerosis.2024.117488_bib3","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jacc.2016.11.055","article-title":"10-Year clinical outcome after Randomization to treatment by sirolimus- or Paclitaxel-eluting coronary stents","volume":"6","author":"Gall\u00f8e","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"37","key":"10.1016\/j.atherosclerosis.2024.117488_bib4","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1093\/eurheartj\/ehw343","article-title":"Ten-year clinical outcomes of first-generation drug-eluting stents: the Sirolimus-Eluting vs. Paclitaxel-Eluting Stents for Coronary Revascularization (SIRTAX) VERY LATE trial","volume":"45","author":"Yamaji","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2024.117488_bib5","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0140-6736(18)31860-9","article-title":"Late clinical outcome of stent trials: a matter of life or death?","volume":"392","author":"von Birgelen","year":"2019","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.atherosclerosis.2024.117488_bib6","doi-asserted-by":"crossref","first-page":"e1022","DOI":"10.4244\/EIJ-D-19-00503","article-title":"Ten-year outcomes from a randomised comparison of zotarolimus-eluting and sirolimus-eluting stents: the SORT OUT III study","volume":"11","author":"Pareek","year":"2019","journal-title":"EuroIntervention"},{"key":"10.1016\/j.atherosclerosis.2024.117488_bib7","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s12471-020-01442-w","article-title":"The 2010s in clinical drug-eluting stent and bioresorbable scaffold research: a Dutch perspective","volume":"28","author":"Kawashima","year":"2020","journal-title":"Neth. Heart J."},{"issue":"35","key":"10.1016\/j.atherosclerosis.2024.117488_bib8","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/HCO.0000000000000786","article-title":"Thin, very thin, or ultrathin-strut biodegradable or durable polymer-coated drug-eluting stents","volume":"6","author":"Buiten","year":"2020","journal-title":"Curr. Opin. Cardiol."},{"issue":"378","key":"10.1016\/j.atherosclerosis.2024.117488_bib9","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0140-6736(11)61672-3","article-title":"Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial","volume":"9807","author":"Stefanini","year":"2011","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2024.117488_bib10","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jcin.2013.04.011","volume":"6","author":"Serruys","year":"2013","journal-title":"JACC Cardiovasc. Interv."},{"issue":"9915","key":"10.1016\/j.atherosclerosis.2024.117488_bib11","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0140-6736(13)62037-1","article-title":"Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (Dutch PEERS): a randomised, single-blind, multicentre, non-inferiority trial","volume":"383","author":"von Birgelen","year":"2014","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.atherosclerosis.2024.117488_bib12","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.jacc.2012.01.008","article-title":"A randomized controlled trial in second-generation zotarolimus-eluting Resolute stents versus everolimus-eluting Xience V stents in real-world patients: the TWENTE trial","volume":"59","author":"von Birgelen","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2024.117488_bib13","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.119.008152","article-title":"Clinical outcomes following implantation of thin-strut, bioabsorbable polymer-coated, everolimus-eluting SYNERGY stents","volume":"12","author":"Kereiakes","year":"2019","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.atherosclerosis.2024.117488_bib14","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.atherosclerosis.2022.05.002","article-title":"Outcome after percutaneous coronary intervention with contemporary stents in patients with concomitant peripheral arterial disease: a patient-level pooled analysis of four randomized trials","volume":"355","author":"Pinxterhuis","year":"2022","journal-title":"Atherosclerosis"},{"issue":"20","key":"10.1016\/j.atherosclerosis.2024.117488_bib15","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s12933-021-01405-4","article-title":"Impact of prediabetes and diabetes on 3-year outcome of patients treated with new-generation drug-eluting stents in two large-scale randomized clinical trials","volume":"1","author":"Ploumen","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"issue":"17","key":"10.1016\/j.atherosclerosis.2024.117488_bib16","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2024.117488_bib17","doi-asserted-by":"crossref","first-page":"871","DOI":"10.4244\/EIJV5I7A146","article-title":"Myocardial infarction adjudication in contemporary all-comer stent trials: balancing sensitivity and specificity. Addendum to the historical MI definitions used in stent studies","volume":"5","author":"Vranckx","year":"2010","journal-title":"EuroIntervention"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2024.117488_bib18","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.jacc.2016.11.008","article-title":"2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines","volume":"69","author":"Gerhard-Herman","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2024.117488_bib19","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","volume":"39","author":"Aboyans","year":"2018","journal-title":"Eur. Heart J."},{"issue":"144","key":"10.1016\/j.atherosclerosis.2024.117488_bib20","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1161\/CIRCULATIONAHA.120.046289","article-title":"Ten-year all-cause death according to completeness of revascularization in patients with three-vessel disease or left main coronary artery disease: insights from the SYNTAX extended survival study","volume":"2","author":"Takahashi","year":"2021","journal-title":"Circulation"},{"issue":"Suppl 2","key":"10.1016\/j.atherosclerosis.2024.117488_bib21","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/ccd.29586","article-title":"Long-term clinical outcomes in transradial versus transfemoral access for left main percutaneous coronary intervention","volume":"97","author":"Gao","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"issue":"218","key":"10.1016\/j.atherosclerosis.2024.117488_bib22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ahj.2019.08.014","article-title":"Long-term (10-year) outcomes of stenting or bypass surgery for acute coronary syndromes and stable ischemic heart disease with unprotected left main coronary artery disease","author":"Park","year":"2019","journal-title":"Am. Heart J."},{"issue":"21","key":"10.1016\/j.atherosclerosis.2024.117488_bib23","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1177\/1358863X16643603","article-title":"Mortality rates at 10 years are higher in diabetic than in non-diabetic patients with chronic lower extremity peripheral arterial disease","volume":"5","author":"Mueller","year":"2016","journal-title":"Vasc. Med."},{"issue":"55","key":"10.1016\/j.atherosclerosis.2024.117488_bib24","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ejvs.2018.01.019","article-title":"Ten year mortality in different peripheral arterial disease stages: a population based observational study on outcome","volume":"4","author":"Sartipy","year":"2018","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"issue":"22","key":"10.1016\/j.atherosclerosis.2024.117488_bib25","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1001\/archinte.167.22.2482","article-title":"A prognostic risk index for long-term mortality in patients with peripheral arterial disease","volume":"167","author":"Feringa","year":"2007","journal-title":"Arch. Intern. Med."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2024.117488_bib26","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.jcin.2013.08.008","article-title":"Prevalence and clinical implications of newly revealed, asymptomatic abnormal ankle-brachial index in patients with significant coronary artery disease","volume":"12","author":"Lee","year":"2013","journal-title":"JACC Cardiovasc. Interv."},{"issue":"219","key":"10.1016\/j.atherosclerosis.2024.117488_bib27","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ijcard.2016.06.102","article-title":"Outcomes following acute hospitalised myocardial infarction in France: an insurance claims database analysis","author":"Blin","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2024.117488_bib28","article-title":"Hypertension and vascular disease","volume":"103S-6S","author":"Doyle","year":"1991","journal-title":"Am. J. Hypertens."},{"issue":"146","key":"10.1016\/j.atherosclerosis.2024.117488_bib29","first-page":"412","article-title":"Smoking tobacco and cancer risk","volume":"6","author":"Scher\u00fcbl","year":"2021","journal-title":"Dtsch. Med. Wochenschr."},{"issue":"108","key":"10.1016\/j.atherosclerosis.2024.117488_bib30","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.amjcard.2011.05.024","article-title":"Long-term predictors of mortality after percutaneous coronary intervention in the era of drug-eluting stents","volume":"7","author":"Wilson","year":"2011","journal-title":"Am. J. Cardiol."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915024000480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915024000480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,19]],"date-time":"2024-05-19T15:58:00Z","timestamp":1716134280000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915024000480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":30,"alternative-id":["S0021915024000480"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2024.117488","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ten-year mortality after treating obstructive coronary atherosclerosis with contemporary stents in patients with or without concomitant peripheral arterial disease","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2024.117488","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"117488"}}